Back
GeneDx Holdings Corp. 10K Form
Sell
24
WGS
GeneDx Holdings Corp.
Last Price:
$79.51
Seasonality Move:
-1.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive WGS News And Ratings
See the #1 stock for the next 7 days that we like better than WGS
WGS Financial Statistics
Sales & Book Value
| Annual Sales: | $427.5M |
|---|---|
| Cash Flow: | $-7.4M |
| Price / Cash Flow: | 156.16 |
| Annual Sales: | $10.54 |
| Price / Book: | 7.32 |
Profitability
| EPS (TTM): | -0.74200 |
|---|---|
| Net Income (TTM): | $-21M |
| Gross Margin: | $278.3M |
| Return on Equity: | -7.62% |
| Return on Assets: | -4.31% |
GeneDx Holdings Corp. Earnings Forecast
Key GeneDx Holdings Corp. Financial Ratios
-
The Gross Profit Margin over the past 7 years for WGS is 65.10%.
-
The Selling, General & Administrative Expenses for WGS have been equal to 55.95% of Gross Profit Margin.
-
The Research & Development expenses have been 16.57% of Revenue.
-
The Net Earning history of WGS is -4.92% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 5 years.
GeneDx Holdings Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | WGS |
| Website: | genedx.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 2.46 |
| Quick Ratio: | 2.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 37.44 |
WGS Technical Analysis vs Fundamental Analysis
Sell
24
GeneDx Holdings Corp. (WGS)
is a Sell
Is GeneDx Holdings Corp. a Buy or a Sell?
-
GeneDx Holdings Corp. stock is rated a SellThe current GeneDx Holdings Corp. [WGS] share price is $76.97. The Score for WGS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.